Loading clinical trials...
Loading clinical trials...
Fecal Microbiota Transplantation (FMT) for Immune-Checkpoint Inhibitor Induced-Diarrhea/Colitis in Genitourinary Cancer Patients
Conditions
Interventions
Fecal Microbiota Transplantation
Loperamide
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
February 1, 2021
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
March 20, 2026
NCT07550673
NCT06372613
NCT07374471
NCT07196410
NCT07215624
NCT07192393
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions